Literature DB >> 7571560

Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience.

J K Stoller1, P A Lange, M K Westveer, W D Carey, D Vogt, J M Henderson.   

Abstract

To ascertain the prevalence and reversibility of the hepatopulmonary syndrome, we reviewed the cases of 98 patients undergoing liver transplantation at the Cleveland (Ohio) Clinic Foundation from June 1988 through July 1992 and identified 4 patients with clinically recognized hepatopulmonary syndrome (prevalence 4%). All 4 patients ultimately had complete reversal of their disorder. As reviewed herein, the prevalence of the hepatopulmonary syndrome in the current series is lower than in previous reports, possibly reflecting a dependence on its clinical recognition in this series rather than the use of routine screening tests. This report confirms previous experience that the hepatopulmonary syndrome may be reversible after transplantation.

Entities:  

Mesh:

Year:  1995        PMID: 7571560      PMCID: PMC1303007     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  38 in total

Review 1.  Pulmonary aspects of liver disease and liver transplantation.

Authors:  M J Krowka; D A Cortese
Journal:  Clin Chest Med       Date:  1989-12       Impact factor: 2.878

Review 2.  Liver transplantation: an overview.

Authors:  W C Maddrey; D H Van Thiel
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

3.  Standardization of spirometry--1987 update. Statement of the American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1987-11

4.  Syndrome of cyanosis, digital clubbing, and hepatic disease in siblings.

Authors:  A Silverman; M D Cooper; J H Moller; R A Good
Journal:  J Pediatr       Date:  1968-01       Impact factor: 4.406

5.  Reversibility of intrapulmonary arteriovenous shunts in liver cirrhosis documented by serial radionuclide perfusion lung scans.

Authors:  N S Chen; C A Barnett; P A Farrer
Journal:  Clin Nucl Med       Date:  1984-05       Impact factor: 7.794

6.  Medical aspects of liver transplantation.

Authors:  D H Van Thiel; R R Schade; J S Gavaler; B W Shaw; S Iwatsuki; T E Starzl
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

7.  Current status of hepatic transplantation.

Authors:  S Iwatsuki; B W Shaw; T E Starzl
Journal:  Semin Liver Dis       Date:  1983-08       Impact factor: 6.115

8.  Reversibility of pulmonary telangiectasia in liver cirrhosis evidenced by serial dynamic pulmonary perfusion imaging.

Authors:  H Shijo; K Nakayama; H Sasaki; T Ueki; S Sakaguchi; H Sakata; M Okumura
Journal:  Clin Nucl Med       Date:  1989-12       Impact factor: 7.794

9.  Reference spirometric values using techniques and equipment that meet ATS recommendations.

Authors:  R O Crapo; A H Morris; R M Gardner
Journal:  Am Rev Respir Dis       Date:  1981-06

10.  Lung volumes in healthy nonsmoking adults.

Authors:  R O Crapo; A H Morris; P D Clayton; C R Nixon
Journal:  Bull Eur Physiopathol Respir       Date:  1982 May-Jun
View more
  21 in total

Review 1.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 2.  Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications.

Authors:  Minoo N Kavarana; Jeffrey A Jones; Robert E Stroud; Scott M Bradley; John S Ikonomidis; Rupak Mukherjee
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-04-23

3.  Assessment of biventricular function in patients with hepatopulmonary syndrome.

Authors:  Stergios Soulaidopoulos; Maria Vlachou; Evangelos Cholongitas; George Giannakoulas; Theofilos Panagiotidis; Maria Drakopoulou; Haralambos Karvounis; Ioannis Goulis
Journal:  Int J Cardiovasc Imaging       Date:  2021-06-10       Impact factor: 2.357

4.  Surgical closure of large splenorenal shunt may accelerate recovery from hepato-pulmonary syndrome in liver transplant patients.

Authors:  Yan-Jun Shi; Patrick Mckiernan; Kyle Soltys; George Mazariegos; Wei-Lin Wang
Journal:  World J Emerg Med       Date:  2020

5.  Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences.

Authors:  P Schenk; V Fuhrmann; C Madl; G Funk; S Lehr; O Kandel; C Müller
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

6.  Hepatopulmonary syndrome: use of extracorporeal life support for life-threatening hypoxia following liver transplantation.

Authors:  Geoffrey M Fleming; Timothy T Cornell; Theodore H Welling; John C Magee; Gail M Annich
Journal:  Liver Transpl       Date:  2008-07       Impact factor: 5.799

7.  Frequency of Hepatopulmonary Syndrome (HPS) Among Patients With Liver Cirrhosis: A Letter to Editor.

Authors:  Ali Mokhtarifar; Hamidreza Azimi; Abbas Esmaeelzadeh; Mahmood Ebrahimi; Seyed Ahmad Eghbali
Journal:  Hepat Mon       Date:  2016-02-27       Impact factor: 0.660

Review 8.  Systemic abnormalities in liver disease.

Authors:  Masami Minemura; Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

9.  Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study.

Authors:  A Morvan; M Gazon; S Duperret; Z Schmitt; P Pradat; K Mohkam; F Aubrun
Journal:  Int J Organ Transplant Med       Date:  2020

10.  Critical care issues in adult liver transplantation.

Authors:  Palepu B Gopal; Dharmesh Kapoor; Ravichandra Raya; M Subrahmanyam; Deven Juneja; B Sukanya
Journal:  Indian J Crit Care Med       Date:  2009 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.